Tissue distribution of lipid peroxidation product acrolein in human colon carcinogenesis

References

• World Health Organization: Global cancer rates could increase by 50% to 15 million by 2020, Geneva. [Cited 2003 Apr 14]. Available from: http://www.who.int/mediacentre/news/releases/2003/pr27/en
   Google Scholar
• Hamilton SR, Vogelstein B, Kudo S, Riboli E, Nakamura S, Hainaut P, Rubio CA, Sobin LH, Fogt F, Winawer SJ, Goldgar DE, Jass JR. Carcinoma of the colon and rectum. Pathology and genetics of tumours of the digestive system—World Health Organization classification of tumours, SR Hamilton, LA Aaltonen. IARC Press, Lyon 2000; 105–119
   Google Scholar
• Wasan HS, Novelli M, Bee J, Bodmer WF. Dietary fat influences on polyp phenotype in multiple intestinal neoplasia mice. Proc Natl Acad Sci USA 1997; 94: 3308–3313
   PubMed Web of Science ®Google Scholar
• Sawa T, Akaike T, Kida K, Fukushima Y, Takagi K, Maeda H. Lipid peroxyl radicals from oxidized oils and heme-iron implication of a high-fat diet in colon carcinogenesis. Cancer Epidemiol Biomarkers Prev 1998; 7: 1007–1012
   PubMed Web of Science ®Google Scholar
• Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, Vogelstein B, Kinzler KW. APC mutations occur early during colorectal tumorigenesis. Nature 1992; 359: 235–237
   PubMed Web of Science ®Google Scholar
• Fodde R, Smits R, Clevers H. APC signal transduction and genetic instability in colorectal cancer. Nar Rev Cancer 2001; 1: 55–67
   PubMed Web of Science ®Google Scholar
• Forrester K, Almoguera C, Han K, Grizzle WE, Perucho M. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 1987; 327: 298–303
   PubMed Web of Science ®Google Scholar
• Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ, Vogelstein B. Prevalence of ras gene mutation in human colorectal cancers. Nature 1987; 327: 293–297
   PubMed Web of Science ®Google Scholar
• Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL. Genetic alterations during colorectal tumour development. N Eng J Med 1988; 319: 523–532
   Google Scholar
• Pfeifer GP. p53 mutation spectra and the role of methylated CpG sequences. Mutat Res 2000; 450: 155–166
   PubMed Web of Science ®Google Scholar
• Eckl PM, Ortner A, Esterbauer H. Genotoxic properties of 4-hydroxyalkenals and analogous aldehydes. Mutat Res 1993; 290: 182–192
   Google Scholar
• Bratsch H, Nair J, Owen WR. Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: Emerging evidence for their role as risk modifiers. Carcinogenesis 1999; 20: 2209–1218
   PubMedGoogle Scholar
• Udilova N, Jurek D, Mariaan B, Gille L, Schulte-Hermann R, Nohl H. Induction of lipid peroxidation in biomembranes by dietary oil components. Food Chem Toxicol 2003; 41: 1481–1489
   PubMed Web of Science ®Google Scholar
• Tokudome S, Yokoyama Y, Kamiya T, Seno K, Okuyama H, Kuriki K, Cheng J, Nakamura T, Fujii T, Ichikawa H, Itoh M. Rationale and study design of dietary intervention in patients polypectomized for tumours of the colorectum. Jpn J Clin Oncol 2002; 32: 550–553
   PubMedGoogle Scholar
• Gackowski D, Banaszkiewicz Z, Rozalski R, Jawien A, Olinski R. Persistent oxidative stress in colorectal carcinoma patients. Int J Cancer 2002; 101: 395–397
   PubMed Web of Science ®Google Scholar
• Kondo S, Toyokuni S, Iwasa Y, Tanaka T, Onodera H, Hiai H, Imamura M. Persistent oxidative stress in human colorectal carcinoma, but not in adenoma. Free Radic Biol Med 1999; 27: 401–410
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Schaur JR, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991; 11: 61–128
   Google Scholar
• Kreuzer T, Grube R, Zarkovic N, Schaur RJ. 4-hydroxynonenal modified the effects of serum growth factors on the expression of the c-fos proto-oncogene and the proliferation of HeLa carcinoma cells. Free Radic Biol Med 1998; 25: 42–49
   PubMed Web of Science ®Google Scholar
• Zarkovic N, Zarkovic K, Schaur RJ, Stolc S, Schlag G, Redl H, Waeg G, Borovic S, Loncaric I, Juric G, Hlavka V. 4-Hydroxynonenal as a second messenger of free radicals and growth modifying factor. Life Sci 1999; 65: 1901–1904
   PubMed Web of Science ®Google Scholar
• Zarkovic N. 4-Hydroxynonenal as a bioactive marker of pathopysiological processes. Mol Asp Med 2003; 24: 281–291
   PubMedGoogle Scholar
• Manzano RG, Wright KA, Twentyman PR. Modulation by acrolein and chloroacetaldechyde of multidrug resistance mediated by multidrug resistance-associated protein (MRP). Clin Cancer Res 1996; 2: 1321–1326
   PubMed Web of Science ®Google Scholar
• Uchida K, Kanematsu M, Sakai K, Matsuda T, Hattori N, Mizuno Y, Suzuki D, Miyata T, Noguchi N, Niki E, Osawa T. Protein-bound acrolein: Potential markers for oxidative stress. Proc Natl Acad Sci USA 1998; 95: 4882–4887
   PubMed Web of Science ®Google Scholar
• Biswal S, Maxwell T, Rangasmy T, Kehrer JP. Modulation of nenzo(a)oirene-induced p53 DNA activity by acrolein. Carcinogenesis 2003; 24: 1401–1406
   PubMedGoogle Scholar
• Tirumalai R, Rajesh Kumar T, Mai KH, Biswal S. Acrolein causes transcriptional induction of phase II genes by activation of Nrf2 in human lung type II epithelial (A549) cells. Toxicol Lett 2002; 132: 27–36
   PubMed Web of Science ®Google Scholar
• Biasi F, Tessitore L, Zanetti D, Citrin JC, Zingaro B, Chiarpotto E, Zarkovic N, Serviddio G, Poli G. Associated changes of lipid peroxidation and transforming growth factor β-1 levels in human colon cancer during tumour progression. Gut 2002; 50: 361–367
   PubMed Web of Science ®Google Scholar
• Kawai Y, Furuhata A, Toyokuni S, Aratani Y, Uchida K. Formation of acrolein-derived 2′-deoxyadenosine in an iron-induced carcinogenesis model. J Biol Chem 2003; 278: 503446–503454
   Google Scholar
• Okamoto K, Toyokuni S, Uchida K, Ogawa O, Takenewa J, Kakehi Y, Kinoshita H, Hattori-Nakakuki Y, Hiai H, Yoshida O. Formation of 8-hydrxy-2-deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins in human renal-cell carcinoma. Int J Cancer 1994; 58: 825–829
   PubMed Web of Science ®Google Scholar
• Finkelstein EI, Nardinin M, Van der Vliet A. Inhibition of neutrophil apoptosis by acrolein: A mechanism of tobacco-related lung disease?. Am J Physiol 2001; 281: 732–739
   PubMed Web of Science ®Google Scholar
• Kirkham PA, Spooner G, Ffoulkes-Jones C, Calvez R. Cigarette smoke triggers macrophage adhesion and activation: Role of lipid peroxidation product and scavenger receptor. Free Radic Biol Med 2003; 35: 697–710
   PubMed Web of Science ®Google Scholar
• Ichihashi K, Osawaa T, Toyokuni S, Uchida K. Endogenous formation of protein adducts with carcinogenic aldehydes. J Biol Chem 2001; 276: 23903–23913
   PubMed Web of Science ®Google Scholar
• Halliwell B, Zhao KC, Whiteman M. The gastrointestinal tract: A major site of antioxidant action?. Free Radic Res 2000; 33: 819–830
   PubMed Web of Science ®Google Scholar
• Halliwell B, Rafter J, Jenner A. Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: Direct or indirect effects? Antioxidant or not?. Am J Clin Nutr 2005; 81: 268S–276S
   PubMed Web of Science ®Google Scholar
• Barrera N, Di Mauro G, Muraca R, Ferrero D, Cavalli G, Fazio VM, Paradisi L, Dianzani MU. Induction of differentiation of human HL-60 cells by hydroxynonenal, a product of lipid peroxidation. Exp Cell Res 1991; 297: 148–152
   Google Scholar
• Zarkovic N, Ilic Z, Jurin M, Schaur RJ, Puhl H, Esterbauer H. Stimulation of HeLa cell growth by physiological concentration of 4-hydroxynonenal. Cell Biochem Func 1993; 11: 279–286
   PubMed Web of Science ®Google Scholar
• Forman HJ, Dickinson DA. Introduction to serial reviews on 4-hydroxy-2-nonenal as a signaling molecule. Free Radic Biol Med 2004; 37: 594–596
   PubMedGoogle Scholar
• Forman HJ, Dickinson DA, Iles KE. HNE—signaling pathways leading to its elimination. Mol Asp Med 2003; 24: 189–194
   PubMedGoogle Scholar
• Luo J, Shi R. Acrolein induces oxidative stress in brain mitochondria. Neurochem Int 2005; 46: 243–252
   PubMed Web of Science ®Google Scholar
• Kehrer JP, Biswal SS. The molecular effects of acrolein. Toxicol Sci 2000; 57: 6–15
   PubMed Web of Science ®Google Scholar
• Zarkovic N, Schaur JR, Puhl H, Jurin M, Esterbauer H. Mutual dependence of growth modifying effects of 4-hydoxynonenal and fetal calf serum in vitro. Free Radic Biol Med 1994; 16: 877–884
   PubMed Web of Science ®Google Scholar
• Sovic A, Borović S, Loncaric I, Kreuzer T, Zarkovic K, Vukovic T, Waeg G, Hrascan R, Wintersteiger R, Klinger R, Zurak N, Schaur RJ, Zarkovic N. The carcinostatic and proapoptotic potential of 4-Hydroxynonenal in HeLa cells is associated with its conjugation to cellular proteins. Anticancer Res 2001; 21: 1997–2004
   PubMed Web of Science ®Google Scholar
• Semlitsch T, Tillian HM, Zarkovic N, Borovic S, Purtscher M, Hohenwarter O, Schaur RJ. Differential influence of the lipid peroxidation product 4-hydroxynonenal on the growth of human lymphatic leukaemia cells and human peripheral blood lymphocytes. Anticancer Res 2002; 22: 1689–1697
   PubMed Web of Science ®Google Scholar